6533b834fe1ef96bd129d7f3

RESEARCH PRODUCT

Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort

Jose M. Martin-morenoVicente Pallarés-carrataláMaria Tellez-plazaJosep RedonAdriana Lopez-pinedaVicente Francisco Gil-guillénAna M Cebrián-cuencaManuel Ruiz-quinteroJesús Bleda-canoAntonio Fernández-giménezJorge Navarro-pérezJose A. QuesadaSara CarrascosaEdelmiro MenéndezConcepción Carratalá-munueraAna María Perez-navarro

subject

Adultmedicine.medical_specialtyhypertensionkidney dysfunctionEndocrinology Diabetes and MetabolismPopulationRenal function030209 endocrinology & metabolismKidneyCohort Studies03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineDiabetes mellitusattributable riskDiabetes MellitusInternal MedicinemedicineHumansCumulative incidenceProspective StudiesRegistries030212 general & internal medicineRenal Insufficiency ChronicProspective cohort studyeducationStrokeeducation.field_of_studyNutrition and Dieteticsbusiness.industrymedicine.diseasemortalitycardiovascular diseasesHospitalizationCardiovascular Diseasesdiabetes mellitusAttributable riskCohortFamily PracticebusinessGlomerular Filtration Rate

description

Abstract Aims To estimate the attributable risk of renal function on all-cause mortality and cardiovascular hospitalization in patients with diabetes. Methods A prospective cohort study in 19,469 adults with diabetes, free of cardiovascular disease, attending primary care in Spain (2008–2011). The estimated glomerular filtration rate (eGFR) and other variables were collected and patients were followed to the first hospitalization for coronary or stroke event, or death, until the end of 2012. The cumulative incidence of the study endpoints by eGFR categories was graphically displayed and adjusted population attributable risks (PARs) for low eGFR was calculated. Results Mean follow-up was 3.2 years and 506 deaths and 1720 hospitalizations were recorded. The cumulative risk for the individual events increased as eGFR levels decreased. The PAR associated with having an eGFR of 60 mL/min/1.73 m2 or less was 11.4% (95% CI 4.8–18.3) for all-cause mortality, 9.2% (95% CI 5.3–13.4) for coronary heart disease, and 2.6% (95% CI −1.8 to 7.4) for stroke. Conclusions Reduced eGFR levels were associated with a larger proportion of avoidable deaths and cardiovascular hospitalizations in people with diabetes compared to previously reported results in people with other cardiovascular risk factors.

https://doi.org/10.1016/j.pcd.2020.06.004